Shanghai Sigma-Audley New Material Technology: difference between revisions
Diff·revision 45 → 46·09:19, 31 Jul 2025
Difference between revision 45 and revision 46 of Shanghai Sigma-Audley New Material Technology. 5 lines changed; the page grew by 271 bytes.
| Revision 45 — 23:22, 22 Jul 2025 PrepHPLC_Pia (talk) add category 10,267 bytes +810 | Revision 46 — 09:19, 31 Jul 2025 Retention_Time_Rae (talk) convert prose to table for comparability 10,538 bytes +271 | ||
|---|---|---|---|
| 83 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 83 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| 84 | 84 | ||
| + | 85 | == Further reading == | |
| + | 86 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 87 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 88 | ||
| 85 | == See also == | 89 | == See also == |
| 86 | * [[Certificate of analysis]] | 90 | * [[Certificate of analysis]] |
| ⋮ | ⋮ | ||
| 90 | * [[Research use only]] | 94 | * [[Research use only]] |
| 91 | * [[Peptide supply chain]] | 95 | * [[Peptide supply chain]] |
| + | 96 | * [[Blind sampling]] | |
| 92 | 97 | ||
| 93 | {{DEFAULTSORT:Shanghai Sigma-Audley New Material Technology}} | 98 | {{DEFAULTSORT:Shanghai Sigma-Audley New Material Technology}} |